Molekulární biologie v onkologii prostaty aneb kudy vede cesta // SOLEN

Urologie pro praxi 6/2002

Molekulární biologie v onkologii prostaty aneb kudy vede cesta

Molecular biology in prostatic oncology and or where is the way Today genetic methods are in the grand development. The volume of the knowledges is growing with development of the research from diagnostic methods to therapy. One of the best known area of urooncology is carcinoma of the prostate. Genetics methods should play important role at pharmacology of the prostate carcinoma. For the present time genetic phramacology utility is plan for hormonal resistent carcinoma of the prostate (HR–CaP). We can expect additional development of gen therapy and it could be at the time of current urologists. Therefore I submit review of current possibilies of gen therapy of prostate carcinoma. Key words: apoptosis, carcinoma of the prostate, therapy, bcl-2, endothelin.